Show source-provided references
1. A combinational threat of micro- and nano-plastics (MNPs) as potential emerging vectors for per- and polyfluoroalkyl substances (PFAS) to human health
10.1007/s10661-024-13292-9 ↗2. Trophic transfer and interfacial impacts of micro(nano)plastics and per- and polyfluoroalkyl substances in the environment
10.1016/j.jhazmat.2023.133243 ↗3. Microplastics in ecosystems: Critical review of occurrence, distribution, toxicity, fate, transport, and advances in experimental and computational studies in surface and subsurface water
10.1016/j.jenvman.2024.122492 ↗6. Sobral, A.F., Cunha, A., Costa, I., Silva-Carvalho, M., Silva, R., and Barbosa, D.J. (2025). Environmental xenobiotics and epigenetic modifications: Implications for human health and disease. J. Xenobiot., 15.
10.3390/jox15040118 ↗7. Microplastics in freshwater and marine ecosystems: Occurrence, characterization, sources, distribution dynamics, fate, transport processes, potential mitigation strategies, and policy interventions
10.1016/j.ecoenv.2025.118036 ↗8. Kovacs, K., Bodis, J., and Vass, R.A. (2025). Microplastics, endocrine disruptors, and oxidative stress: Mechanisms and health implications. Int. J. Mol. Sci., 27.
10.3390/ijms27010399 ↗9. Toxicological interactions of microplastics/nanoplastics and environmental contaminants: Current knowledge and future perspectives
10.1016/j.jhazmat.2020.123913 ↗10. Recent advances in toxicological research and potential health impact of microplastics and nanoplastics in vivo
10.1007/s11356-022-19745-3 ↗11. Ullah, S., Ahmad, S., Guo, X., Ullah, S., Ullah, S., Nabi, G., and Wanghe, K. (2023). A review of the endocrine disrupting effects of micro and nano plastic and their associated chemicals in mammals. Front. Endocrinol., 13.
10.3389/fendo.2022.1084236 ↗12. Bora, S.S., Gogoi, R., Sharma, M.R., Borah, M.P., Deka, P., Bora, J., Naorem, R.S., Das, J., and Teli, A.B. (2024). Microplastics and human health: Unveiling the gut microbiome disruption and chronic disease risks. Front. Cell. Infect. Microbiol., 14.
10.3389/fcimb.2024.1492759 ↗13. Chulkov, V., Gasanov, M., Isakov, V., Denisenko, A., Nwosu, C., and Rodkin, S. (2025). Molecular and cellular effects of microplastics and nanoplastics in the pathogenesis of cardiovascular, nervous, urinary, digestive, and reproductive system diseases: A global systematic review. Int. J. Mol. Sci., 26.
10.3390/ijms262211194 ↗14. Bhattacharyya, S., Greer, M.L., and Salehi, M. (2025). Impact of micro- and nanoplastics exposure on human health: Focus on neurological effects from ingestion. Front. Public Health, 13.
10.3389/fpubh.2025.1681776 ↗16. Principi, N., Argentiero, A., Campana, B.R., Seferi, H., Cinti, E., and Esposito, S. (2025). Plastic pollution and child health: A narrative review of micro- and nanoplastics, additives, and developmental risks. J. Clin. Med., 14.
10.3390/jcm14238399 ↗17. Fanghella, F., Pesce, M., Franceschelli, S., Panella, V., Elsallabi, O., Lupi, T., Rizza, B., Di Battista, M.G., Bruno, A., and Ballerini, P. (2025). Biological modulation of autophagy by nanoplastics: A current overview. Int. J. Mol. Sci., 26.
10.3390/ijms26157035 ↗18. Innovations in the development of promising adsorbents for the remediation of microplastics and nanoplastics—A critical review
10.1016/j.watres.2022.119526 ↗20. Tripathi, M., Singh, P., Pathak, S., Manimekalai, R., Garg, D., and Dashora, K. (2025). Strategies for the remediation of micro- and nanoplastics from contaminated food and water: Advancements and challenges. J. Xenobiot., 15.
10.3390/jox15010030 ↗21. Liang, N., and Kitts, D.D. (2016). Role of chlorogenic acids in controlling oxidative and inflammatory stress conditions. Nutrients, 8.
10.3390/nu8010016 ↗25. Current status of using adsorbent nanomaterials for removing microplastics from water supply systems: A mini review
10.3762/bjnano.16.127 ↗26. Di Giacomo, A., Russo, G.L., Moccia, S., Spagnuolo, C., and Russo, M. (2026). Phytochemicals possess selective chemopreventive mechanisms that safeguard human cells from oxidative toxicity. Biomolecules, 16.
10.3390/biom16020191 ↗28. Polyphenols regulate the activity of endocrine-disrupting chemicals, having both positive and negative effects
10.3390/jox14040077 ↗29. Bas, T.G. (2026). Dietary polyphenols (flavonoids) derived from plants for use in therapeutic health: Antioxidant performance, ROS, molecular mechanisms, and bioavailability limitations. Int. J. Mol. Sci., 27.
10.3390/ijms27031404 ↗30. Transactivation of genes encoding for phase II enzymes and phase III transporters by phytochemical antioxidants
10.3390/molecules15096332 ↗31. Stoian, I.A., Vlad, A., Gilca, M., and Dragos, D. (2025). Modulation of glutathione-S-transferase by phytochemicals: To activate or inhibit—That is the question. Int. J. Mol. Sci., 26.
10.3390/ijms26157202 ↗32. Mehta, J., Rayalam, S., and Wang, X. (2018). Cytoprotective effects of natural compounds against oxidative stress. Antioxidants, 7.
10.3390/antiox7100147 ↗33. Mączka, W., Grabarczyk, M., and Wińska, K. (2022). Can antioxidants reduce the toxicity of bisphenol?. Antioxidants, 11.
10.3390/antiox11020413 ↗35. Wang, Z., Wang, Y., Zhang, J., Feng, G., Miao, S., Lu, R., Tian, X., and Ye, Y. (2025). Antioxidant intervention against microplastic hazards. Antioxidants, 14.
10.3390/antiox14070797 ↗36. Dietary phytochemicals in health and disease: Mechanisms, clinical evidence, and applications—A comprehensive review
10.1002/fsn3.70101 ↗37. Singh, D.D., Yadav, D.K., and Shin, D. (2026). Phytochemicals and redox modulation: Molecular mechanisms, clinical relevance, and therapeutic perspectives. Antioxidants, 15.
10.3390/antiox15020272 ↗38. Cimmino, I., Fiory, F., Perruolo, G., Miele, C., Beguinot, F., Formisano, P., and Oriente, F. (2020). Potential mechanisms of bisphenol A (BPA) contributing to human disease. Int. J. Mol. Sci., 21.
10.3390/ijms21165761 ↗39. Della Rocca, Y., Traini, E.M., Diomede, F., Fonticoli, L., Trubiani, O., Paganelli, A., Pizzicannella, J., and Marconi, G.D. (2023). Current evidence on bisphenol A exposure and the molecular mechanism involved in related pathological conditions. Pharmaceutics, 15.
10.3390/pharmaceutics15030908 ↗40. Bisphenol A distribution in serum, urine, placenta, breast milk, and umbilical cord serum in a birth panel of mother–neonate pairs
10.1016/j.scitotenv.2017.10.042 ↗42. Non-monotonic dose responses in studies of endocrine disrupting chemicals: Bisphenol A as a case study
44. Lee, J.L., Wang, Y.C., Hsu, Y.A., Chen, C.S., Weng, R.C., Lu, Y.P., Chuang, C.Y., and Wan, L. (2022). Bisphenol A coupled with a high-fat diet promotes hepatosteatosis through reactive oxygen species-induced CD36 overexpression. Toxics, 10.
10.3390/toxics10050208 ↗45. Disruption of PPARG activity and CPT1A regulation by bisphenol A: Implications for hepatic lipid metabolism
10.1111/jcmm.70416 ↗46. Impact of polystyrene microplastic exposure on lipid profile and oxidative stress status of male and female Wistar rats
10.5620/eaht.2022024 ↗47. Salau, E.A.H., Diglio, D., Guimarães, G.R., Furtado-Filho, O.V., and Porawski, M. (2025). Bisphenol A alters the expression of genes involved in lipogenesis, inflammation, and oxidative stress in the liver of adult zebrafish. Pharmaceuticals, 18.
10.3390/ph18111765 ↗48. Liu, R., Liu, B., Tian, L., Jiang, X., Li, X., Cai, D., Sun, J., Bai, W., and Jin, Y. (2022). Exposure to bisphenol A caused hepatotoxicity and intestinal flora disorder in rats. Int. J. Mol. Sci., 23.
10.3390/ijms23148042 ↗49. G protein-coupled estrogen receptor activation by bisphenol A disrupts lipid metabolism and induces ferroptosis in the liver
10.1016/j.envpol.2023.122211 ↗50. Involvement of the G-protein-coupled estrogen receptor-1 (GPER) signaling pathway in neurodegenerative disorders: A review
10.1007/s10571-022-01301-9 ↗51. Xu, F., Ma, J., Wang, X., Wang, X., Fang, W., Sun, J., Li, Z., and Liu, J. (2023). The role of G protein-coupled estrogen receptor (GPER) in vascular pathology and physiology. Biomolecules, 13.
10.3390/biom13091410 ↗53. Bisphenol A and related alkylphenols exert nongenomic estrogenic actions through a G protein-coupled estrogen receptor 1 (GPER)/epidermal growth factor receptor (EGFR) pathway to inhibit meiotic maturation of zebrafish oocytes
10.1095/biolreprod.115.132316 ↗55. Gassman, N.R. (2022). Classical and non-classical estrogen receptor effects of bisphenol A. Bisphenol A: A Multi-Modal Endocrine Disruptor, Royal Society of Chemistry.
10.1039/9781839166495 ↗56. Low concentrations of bisphenol A suppress thyroid hormone receptor transcription through a nongenomic mechanism
10.1016/j.taap.2011.12.018 ↗57. Mechanisms of bisphenol A and its analogs as endocrine disruptors via nuclear receptors and related signaling pathways
10.1007/s00204-025-04025-z ↗58. Induction of oxidative stress by bisphenol A and its pleiotropic effects
10.1002/em.22072 ↗60. Bisphenol A, bisphenol S, bisphenol F and bisphenol AF induce different oxidative stress and damage in human red blood cells (in vitro study)
10.1016/j.tiv.2017.02.018 ↗61. Sex-specific changes in oxidative stress parameters and longevity produced by bisphenol F and S compared to bisphenol A in Drosophila melanogaster
10.1016/j.cbpc.2022.109329 ↗63. Bisphenol A induces testicular oxidative stress in mice leading to ferroptosis
10.4103/aja202266 ↗64. Unravelling bisphenol A-induced hepatotoxicity: Insights into oxidative stress, inflammation, and energy dysregulation
10.1016/j.envpol.2024.124922 ↗65. Caporossi, L., and Papaleo, B. (2017). Bisphenol A and metabolic diseases: Challenges for occupational medicine. Int. J. Environ. Res. Public Health, 14.
10.3390/ijerph14090959 ↗66. Moghazy, M., Papathanasiou, M., Tzoupis, H., Papavasileiou, K.D., Xing, C., Lauschke, V.M., Afantitis, A., and Melagraki, G. (2025). A systematic literature review of reproductive toxicological studies on phthalates. Int. J. Mol. Sci., 26.
10.3390/ijms26188761 ↗67. Ferroptosis is critical for phthalates driving the blood–testis barrier dysfunction via targeting transferrin receptor
10.1016/j.redox.2022.102584 ↗69. Hlisníková, H., Petrovičová, I., Kolena, B., Šidlovská, M., and Sirotkin, A. (2020). Effects and mechanisms of phthalates’ action on reproductive processes and reproductive health: A literature review. Int. J. Environ. Res. Public Health, 17.
10.3390/ijerph17186811 ↗71. Exposure to DEHP and MEHP from hatching to adulthood causes reproductive dysfunction and endocrine disruption in marine medaka (Oryzias melastigma)
10.1016/j.aquatox.2013.10.025 ↗74. Mono-(2-ethylhexyl) phthalate-induced disruption of junctional complexes in the seminiferous epithelium of the rodent testis is mediated by MMP2
10.1095/biolreprod.109.080374 ↗76. Revealing the impact of mono(2-ethylhexyl) phthalate (MEHP) on prostate cancer based on network toxicology and molecular docking approaches
10.1002/jat.4826 ↗77. Chemical activity-based environmental risk analysis of the plasticizer di-ethylhexyl phthalate and its main metabolite mono-ethylhexyl phthalate
10.1002/etc.3689 ↗78. Exploring the reproductive exposure risks of phthalates and organophosphates in atmospheric particulate matter based on quantitative structure–activity relationships and network toxicology models
10.1016/j.jhazmat.2025.137395 ↗81. The endocrine disruptor mono-(2-ethylhexyl) phthalate promotes adipocyte differentiation and induces obesity in mice
10.1042/BSR20120042 ↗82. Jia, Y., Liu, T., Zhou, L., Zhu, J., Wu, J., Sun, D., Xu, J., Wang, Q., Chen, H., and Xu, F. (2016). Effects of di-(2-ethylhexyl) phthalate on lipid metabolism by the JAK/STAT pathway in rats. Int. J. Environ. Res. Public Health, 13.
10.3390/ijerph13111085 ↗83. DEHP exposure destroys blood–testis barrier (BTB) integrity of immature testes through excessive ROS-mediated autophagy
10.1016/j.gendis.2018.06.004 ↗84. Absorption, distribution, and toxicity of per- and polyfluoroalkyl substances (PFAS) in the brain: A review
10.1039/D1EM00228G ↗85. Mišľanová, C., and Valachovičová, M. (2025). Health impacts of per- and polyfluoroalkyl substances (PFASs): A comprehensive review. Life, 15.
10.3390/life15040573 ↗86. Per- and polyfluoroalkyl substance toxicity and human health review: Current state of knowledge and strategies for informing future research
10.1002/etc.4890 ↗88. Association between exposure to per- and perfluoroalkyl substances (PFAS) and reproductive hormones in human: A systematic review and meta-analysis
10.1016/j.envres.2023.117553 ↗90. Emerging toxicological awareness of per- and polyfluoroalkyl substances: The rising concern over “forever chemicals”
10.1242/dmm.052647 ↗91. Brenckman, C.M., Borgaonkar, A.D., Pennock, W.H., and Meegoda, J.N. (2026). Combined environmental impacts and toxicological interactions of per- and polyfluoroalkyl substances (PFAS) and microplastics (MPs). Environments, 13.
10.3390/environments13010038 ↗92. Neurotransmission targets of per- and polyfluoroalkyl substance neurotoxicity: Mechanisms and potential implications for adverse neurological outcomes
10.1021/acs.chemrestox.2c00072 ↗93. Brunetti, K., Galletti, G.S., Catalani, E., Cervia, D., and Del Quondam, S. (2025). From exposure to dysfunction: The intestinal toxicity of per- and polyfluoroalkyl substances. Toxics, 14.
10.3390/toxics14010039 ↗96. Monitoring of per- and polyfluoroalkyl substances (PFAS) in human blood samples collected in three regions with known PFAS releases in the environment and three control regions in South Germany
10.1007/s00204-024-03843-x ↗97. Per- and polyfluoroalkyl substances in blood plasma—Results of the German Environmental Survey for children and adolescents 2014–2017 (GerES V)
10.1016/j.ijheh.2020.113549 ↗98. Early-life exposure to per- and polyfluoroalkyl substances: Analysis of levels, health risk and binding abilities to transport proteins
10.1016/j.eehl.2024.04.007 ↗100. Association between per- and polyfluoroalkyl substances exposure and prevalence of chronic obstructive pulmonary disease: The mediating role of serum albumin
10.1016/j.scitotenv.2024.171742 ↗